Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Common Stock
Shares outstanding
46,377,939
Total 13F shares
22,224,435
Share change
+1,576,663
Total reported value
$442,228,625
Price per share
$19.90
Number of holders
129
Value change
+$31,389,222
Number of buys
71
Number of sells
39

Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2018

As of 31 Dec 2018, Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,224,435 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, FEDERATED INVESTORS INC /PA/, Invesco Ltd., STATE STREET CORP, TEACHERS ADVISORS, LLC, NORTHERN TRUST CORP, Bank of New York Mellon Corp, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 129 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.